Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/455
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBURZYKOWSKI, Tomasz-
dc.contributor.authorMOLENBERGHS, Geert-
dc.contributor.authorBUYSE, Marc-
dc.contributor.authorGEYS, Helena-
dc.contributor.authorRENARD, Didier-
dc.date.accessioned2004-11-04T08:32:35Z-
dc.date.available2004-11-04T08:32:35Z-
dc.date.issued2000-
dc.identifier.citationProceedings of the Biopharmaceutical Section, American Statistical Association. p. 40-45.-
dc.identifier.isbn9781883276874-
dc.identifier.urihttp://hdl.handle.net/1942/455-
dc.language.isoen-
dc.publisherAmerican Statistical Association-
dc.subjectClustered data-
dc.subjectClinical trials-
dc.subjectSurvival analysis-
dc.subjectSurrogate Markers-
dc.titleValidation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints-
dc.typeProceedings Paper-
local.bibliographicCitation.conferencenameProceedings of the Biopharmaceutical Section, American Statistical Association-
dc.identifier.epage45-
dc.identifier.spage40-
local.bibliographicCitation.jcatC1-
local.type.refereedRefereed-
local.type.specifiedProceedings Paper-
dc.bibliographicCitation.oldjcatC2-
local.bibliographicCitation.btitleProceedings of the Biopharmaceutical Section, American Statistical Association 1999-
item.fulltextNo Fulltext-
item.accessRightsClosed Access-
item.fullcitationBURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena & RENARD, Didier (2000) Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints. In: Proceedings of the Biopharmaceutical Section, American Statistical Association. p. 40-45..-
item.contributorBURZYKOWSKI, Tomasz-
item.contributorMOLENBERGHS, Geert-
item.contributorBUYSE, Marc-
item.contributorGEYS, Helena-
item.contributorRENARD, Didier-
Appears in Collections:Research publications
Show simple item record

Page view(s)

82
checked on May 23, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.